TIMOLIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Timolide, and when can generic versions of Timolide launch?
Timolide is a drug marketed by Merck and is included in one NDA.
The generic ingredient in TIMOLIDE is hydrochlorothiazide; timolol maleate. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; timolol maleate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TIMOLIDE?
- What are the global sales for TIMOLIDE?
- What is Average Wholesale Price for TIMOLIDE?
Summary for TIMOLIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TIMOLIDE at DailyMed |
US Patents and Regulatory Information for TIMOLIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | TIMOLIDE 10-25 | hydrochlorothiazide; timolol maleate | TABLET;ORAL | 018061-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
